20/20 GeneSystems

Artificial intelligence-powered diagnostics for cancer & COVID-19

Analytics

Raised to Date: Raised: $3,792,229

Aggregate Commitments $

Platform

SeedInvest

Start Date

08/17/2018

Close Date

11/01/2020

Min. Goal

$10

Max. Goal

$14,700,000

Min. Investment

$502

Security Type

Equity - Preferred

Funding Type

RegA+

Pre-Money Valuation

$38,500,000

Rolling Commitments $

Status
Funded
Reporting Date

11/01/2020

Days Remaining
Funded
% of Min. Goal

37,922,290%

% of Max. Goal

26%

Likelihood of Max
Funded
Avg. Daily Raise

$4,699

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

Rockville, Maryland

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

20/20 GeneSystems, with a pre-money valuation of $38.5 million, is raising funds on SeedInvest through Reg A+ crowdfunding. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. The company has recently launched CoronaCheck; its FDA authorized antibody lab test for COVID-19 antibodies. 20/20 GeneSystems was founded by Jonathan Cohen and has raised over $10 million in previous rounds of financing. The current round of funding has round size of $14,700,000, and the proceeds will be used for sales and marketing, research and development, intellectual property development and protection, and cybersecurity and patient privacy protections. 20/20 GeneSystems has already sold over 70,000 COVID-19 antibody tests since its launch in March 2020 and generated over $1.2 million in revenue.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
20/20 GeneSystems 11/15/2022 StartEngine $58,400,000 $114,564 Convertible Note Active RegCF
20/20 GeneSystems 06/27/2021 StartEngine $38,500,000 $2,903,017 Equity - Preferred Funded RegA+
20/20 GeneSystems 11/01/2020 SeedInvest $38,500,000 $3,792,229 Equity - Preferred Funded RegA+
20/20 GeneSystems 12/14/2017 Microventures $23,000,000 $1,064,807 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
20/20 GeneSystems on SeedInvest
$
Platform: SeedInvest
Security Type: Equity - Preferred
Valuation: $38,500,000
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow 20/20 GeneSystems on SeedInvest
View on SeedInvest (Closed)
Bullish / Bearish
You're Bullish on 20/20 GeneSystems on SeedInvest

Thank you for your vote on 20/20 GeneSystems on SeedInvest

Bullish / Bearish
You're Bearish on 20/20 GeneSystems on SeedInvest

Thank you for your vote on 20/20 GeneSystems on SeedInvest